PlainRecalls
FDA Drug Moderate Class II Ongoing

Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Accord Healthcare Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad 382 213, India. Mfg. Lic. No.: G/28/1336, NDC 16729-288-38

Reported: October 23, 2024 Initiated: October 1, 2024 #D-0010-2025

Product Description

Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Accord Healthcare Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad 382 213, India. Mfg. Lic. No.: G/28/1336, NDC 16729-288-38

Reason for Recall

Failed Impurities/Degradation Specifications.

Details

Recalling Firm
ACCORD HEALTHCARE, INC.
Units Affected
11,214 vials
Distribution
Nationwide within the United States and PR
Location
Raleigh, NC

Frequently Asked Questions

What product was recalled?
Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Accord Healthcare Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad 382 213, India. Mfg. Lic. No.: G/28/1336, NDC 16729-288-38. Recalled by ACCORD HEALTHCARE, INC.. Units affected: 11,214 vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 23, 2024. Severity: Moderate. Recall number: D-0010-2025.